{"id":"https://openalex.org/W2777094238","doi":"https://doi.org/10.1080/10799893.2017.1414843","title":"An optimized protocol for thein vitrogeneration and functional analysis of human PD1/PD-L1 signal","display_name":"An optimized protocol for thein vitrogeneration and functional analysis of human PD1/PD-L1 signal","alternate_titles":[],"publication_year":2017,"publication_date":"2017-12-18","ids":{"openalex":"https://openalex.org/W2777094238","doi":"https://doi.org/10.1080/10799893.2017.1414843","mag":"2777094238","pmid":"https://pubmed.ncbi.nlm.nih.gov/29252078"},"language":"en","primary_location":{"id":"doi:10.1080/10799893.2017.1414843","doi":"https://doi.org/10.1080/10799893.2017.1414843","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10799893.2017.1414843","pdf_url":null,"source":{"id":"https://openalex.org/S116485566","display_name":"Journal of Receptors and Signal Transduction","issn_l":"1079-9893","issn":["1079-9893","1532-4281"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Receptors and Signal Transduction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2777094238"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039339727","display_name":"Mostafa Khedri","orcid":"https://orcid.org/0000-0001-8590-1534","observed_orcids":["https://orcid.org/0000-0001-8590-1534"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mostafa Khedri","raw_affiliation_strings":["Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066655870","display_name":"Khalil Abnous","orcid":"https://orcid.org/0000-0001-6314-0164","observed_orcids":["https://orcid.org/0000-0001-6314-0164"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Khalil Abnous","raw_affiliation_strings":["Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran;","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039260981","display_name":"Houshang Rafatpanah","orcid":"https://orcid.org/0000-0002-1061-5864","observed_orcids":["https://orcid.org/0000-0002-1061-5864"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Houshang Rafatpanah","raw_affiliation_strings":["Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049264762","display_name":"Mohammad Ramezani","orcid":"https://orcid.org/0000-0001-5888-6703","observed_orcids":["https://orcid.org/0000-0001-5888-6703"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Mohammad Ramezani","raw_affiliation_strings":["Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5049264762"],"corresponding_institution_ids":["https://openalex.org/I165560825"],"apc_list":null,"apc_paid":null,"fwci":0.6544,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.69128484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"38","issue":"1","first_page":"31","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":1.0},{"id":"https://openalex.org/keywords/pd-1-pd-l1-signaling","display_name":"PD-1/PD-L1 signaling","score":0.9300000071525574},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6430000066757202},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.5600000023841858},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7210000157356262},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8199999928474426},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8399999737739563},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.824999988079071},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.9620000123977661},{"id":"https://openalex.org/keywords/preclinical-models","display_name":"preclinical models","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.552316427230835},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5397132635116577},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5201490521430969},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5071661472320557},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47859618067741394},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4766172468662262},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46030381321907043},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.44549280405044556},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43969330191612244},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4303808808326721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35908669233322144},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3399622142314911},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32831406593322754},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26961755752563477},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.24451130628585815},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13644364476203918}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061027","descriptor_name":"Programmed Cell Death 1 Ligand 2 Protein","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061027","descriptor_name":"Programmed Cell Death 1 Ligand 2 Protein","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/10799893.2017.1414843","doi":"https://doi.org/10.1080/10799893.2017.1414843","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10799893.2017.1414843","pdf_url":null,"source":{"id":"https://openalex.org/S116485566","display_name":"Journal of Receptors and Signal Transduction","issn_l":"1079-9893","issn":["1079-9893","1532-4281"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Receptors and Signal Transduction","raw_type":"journal-article"},{"id":"pmid:29252078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29252078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of receptor and signal transduction research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7219111123","display_name":null,"funder_award_id":"930611","funder_id":"https://openalex.org/F4320322855","funder_display_name":"Mashhad University of Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320322855","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W2016789384","https://openalex.org/W2017712207","https://openalex.org/W2063264144","https://openalex.org/W2066002010","https://openalex.org/W2086397613","https://openalex.org/W2089015169","https://openalex.org/W2104750134","https://openalex.org/W2122639773","https://openalex.org/W2130506153","https://openalex.org/W2131577873","https://openalex.org/W2150640296","https://openalex.org/W2277129094","https://openalex.org/W2558960817","https://openalex.org/W2613592469","https://openalex.org/W2752031457","https://openalex.org/W2761400095","https://openalex.org/W3004139131"],"related_works":["https://openalex.org/W3047218414","https://openalex.org/W2810901728","https://openalex.org/W2399033183","https://openalex.org/W4404065645","https://openalex.org/W4377565571","https://openalex.org/W2381960849","https://openalex.org/W2081447339","https://openalex.org/W4313374476","https://openalex.org/W3170010205","https://openalex.org/W1981254820"],"abstract_inverted_index":{"Programmed":[0],"cell":[1,131],"death-1":[2],"(PD1)":[3],"is":[4],"an":[5,29],"inhibitory":[6,30],"receptor":[7],"expressed":[8],"on":[9],"the":[10,33,82,93,100,140],"activated":[11,34],"T":[12,35,130,148],"and":[13,23,78,90,110,117,136,139,160,162],"B":[14],"cells.":[15,36],"Binding":[16],"of":[17,52,57,72,92,120,125,147],"PD1":[18],"to":[19,27,80,97],"its":[20,64],"ligands,":[21],"PD-L1":[22,142],"PD-L2":[24],"has":[25,41,181],"led":[26],"deliver":[28],"signal":[31,170,179],"into":[32],"Recently,":[37],"blocking":[38],"PD1/PD-L1":[39,86,122,151,169,178,197],"pathway":[40],"emerged":[42],"as":[43,189],"a":[44,49,108,167,190],"new":[45],"treatment":[46],"paradigm":[47],"across":[48],"broad":[50],"spectrum":[51],"malignancies.":[53],"Remarkable":[54],"clinical":[55],"responses":[56],"monoclonal":[58],"antibodies":[59,138],"specific":[60],"for":[61,113,145,193],"PD-1":[62],"or":[63],"ligands":[65],"in":[66,99,114,176,184],"patients":[67],"with":[68],"many":[69],"different":[70],"types":[71],"cancer,":[73],"attracted":[74],"several":[75],"pharmaceutical":[76],"companies":[77],"researchers":[79],"investigate":[81],"agents":[83,94],"that":[84,166,175,180],"block":[85],"signal.":[87],"The":[88],"safety":[89],"efficacy":[91],"are":[95],"needed":[96],"examine":[98],"preclinical":[101,194],"studies.":[102],"In":[103,153],"this":[104,154,185],"study,":[105],"we":[106],"optimized":[107,183],"facile":[109],"cost-effective":[111],"protocol":[112,192],"vitro":[115,177],"generation":[116],"functional":[118],"analysis":[119],"human":[121],"pathway.":[123,152,198],"Activation":[124],"CD8":[126],"+":[127,129],"CD279":[128],"was":[132,143,171],"performed":[133],"by":[134],"anti-CD3":[135],"D28":[137],"recombinant":[141],"used":[144],"inactivation":[146],"cells":[149],"through":[150],"protocol,":[155],"T-cell":[156],"cytokine":[157],"production":[158],"(IL-2":[159],"IFN-\u03b3)":[161],"proliferation":[163],"assay":[164],"confirmed":[165],"measurable":[168],"generated.":[172],"We":[173],"expected":[174],"been":[182],"study":[186],"will":[187],"serve":[188],"valuable":[191],"studies":[195],"involving":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2777094238","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-01-05T00:00:00"}
